APMD

Apnimed, Inc.

There isn't enough reported data to score APMD yet.

APMD Fundamentals

MetricStatus
Unavailable
Unavailable
Unavailable
Unavailable

There isn't enough reported data to rate APMD's fundamentals.

APMD PE Valuation

APMD has no meaningful PE right now: it lost money over the past year.

APMD Forward outlook

There aren't enough analyst estimates for APMD to show an outlook.

APMD Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $16.63 on Nov 12.

There is not enough scenario data to assess APMD's risk to reward.

APMD Earnings Per Share

APMD Quarterly Revenue

Q2 2026: $12M
Q2 2026: $12M

APMD Free Cash Flow

Q2 2026: --
Q2 2026: --

APMD Total Shares

Q2 2026: 32M
Q2 2026: 32M

APMD Net Leverage

APMD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

APMD Weekly Momentum

MetricValueStatus
RSI54.5Neutral
Stochastic6.9Oversold

APMD's weekly RSI is 55 (neutral) and its Stochastic is 7 (oversold).

APMD PE vs Healthcare Sector

APMD has no meaningful PE right now: it lost money over the past year.

APMD Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$18.38.9% below

APMD is in a downtrend: it's below all one of its weekly moving averages, and 8.9% below its 8-week average.

APMD Yearly ROI

YearStart priceEnd priceROI
2026 YTD$25.0$16.6-33%

It's down 33% so far in 2026.

Give your agent the market.

Get API key